Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2012:2012:384054.
doi: 10.1155/2012/384054. Epub 2012 Jan 5.

Anaphylaxis triggered by benzyl benzoate in a preparation of depot testosterone undecanoate

Gregory S Y Ong  1 , Colin P Somerville, Timothy W Jones, John P Walsh
Affiliations
Case Reports

Anaphylaxis triggered by benzyl benzoate in a preparation of depot testosterone undecanoate

Gregory S Y Ong et al. Case Rep Med. 2012.

Abstract

We report the first case of an anaphylactic reaction to Reandron 1000 (depot testosterone undecanoate with a castor oil and benzyl benzoate vehicle). While considered to have a favourable safety profile, serious complications such as oil embolism and anaphylaxis can occur. In our patient, skin testing identified benzyl benzoate to be the trigger, with no reaction to castor oil or testosterone undecanoate components. As benzyl benzoate exists in multiple pharmaceuticals, foods, and cosmetics, individual components of pharmaceuticals should be tested when investigating drug allergies. Doctors should be alert to the potential for serious reactions to any of the components of Reandron 1000.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Schubert M, Minnemann T, Hübler D, et al. Intramuscular testosterone undecanoate: pharmacokinetic aspects of a novel testosterone formulation during long-term treatment of men with hypogonadism. Journal of Clinical Endocrinology and Metabolism. 2004;89(11):5429–5434. - PubMed
    1. Nieschlag E. Testosterone treatment comes of age: new options for hypogonadal men. Clinical Endocrinology. 2006;65(3):275–281. - PubMed
    1. Wang L, Shi DC, Lu SY, Fang RY. The therapeutic effect of domestically produced testosterone undecanoate in Klinefelter syndrome. New Drug Market. 1991;8:28–32.
    1. Reandron. 1000 [Data Sheet]. Auckland (New Zealand): Bayer New Zealand Limited, 2010.
    1. Behre HM, Abshagen K, Oettel M, Hübler D, Nieschlag E. Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: phase I studies. European Journal of Endocrinology. 1999;140(5):414–419. - PubMed

Publication types